Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,446 total articles
Hallador Energy announced the acquisition of approximately 460 MW of Siemens turbines and ancillary equipment for $350 million, plus additional refurbishment costs, securing critical assets for its Merom natural gas-fired power project. The acquisition significantly reduces development timing risk amid supply constraints, positioning the company to…
The XAI Octagon Floating Rate & Alternative Income Trust announced its monthly common share distribution of $0.225 per share, unchanged from the previous month. The distribution is payable on July 1, 2026, to shareholders of record as of June 15, 2026. The Trust invests primarily in floating rate credit instruments and structured credit investments…
Praxis Precision Medicines announced that the Phase 2/3 POWER1 study of vormatrigine in patients with focal onset seizures did not meet its primary endpoint of seizure frequency reduction, though a secondary measure of 50% response rate was met and higher dose showed more pronounced seizure reduction. Vormatrigine was generally well-tolerated with …
JM Group Limited, a Hong Kong-based sourcing and wholesale solutions provider, provided an update concerning the ongoing trading halt on its securities by the NYSE. The company disclosed that its special committee, with assistance from outside counsel, is conducting an internal investigation related to the halt. It has responded to all inquiries an…
Microchip Technology Incorporated announced the appointment of Mitch Little, former senior executive at Microchip, to its Board of Directors effective June 1, 2026. Little brings extensive experience in sales, product management, and leadership, and meets Nasdaq's independence requirements. The company highlighted his role in shaping Microchip's cu…
Microchip Technology Incorporated disclosed that its Data Center Solutions Business Unit generated $302.7 million in revenue in 2025 and anticipates approximately 65% growth to about $500 million in 2026. This accelerated growth underscores Microchip's expanding presence in data center components, including storage controllers, PCIe and CXL memory …
LXP Industrial Trust has reported robust leasing performance, completing 4.6 million square feet of leases year-to-date with significant rental rate increases. The company also acquired a prime 37-acre redevelopment site in Phoenix for $103 million, which is fully leased until 2031 and planned for future industrial development. Following these oper…
Microchip Technology Incorporated announced it will present at the B of A Securities Global Technology Conference 2026 on June 2, 2026. The presentation will feature CEO Steve Sanghi and CFO Eric Bjornholt and will be webcast live. Microchip is a leading supplier of semiconductor solutions across multiple sectors including industrial, automotive, c…
California Water Service (Cal Water) has earned the prestigious G480 Platinum Certification from the Alliance for Water Efficiency, recognizing its leadership in water-use efficiency and conservation program management under the updated G480-25 standard. This achievement highlights Cal Water's commitment to sustainability, high-quality service, and…
UroGen Pharma Ltd., a biotech company focused on urothelial and specialty cancers, announced its management will present at the Goldman Sachs 47th Annual Global Healthcare Conference in June 2026. The presentation will include a fireside chat and investor meetings, with a webcast available on UroGen's website.
Minerva Neurosciences has established a Scientific Advisory Board (SAB) composed of leading experts in psychiatry and neuroscience to guide the clinical development of roluperidone, an investigational drug targeting negative symptoms of schizophrenia, and to advise on future pipeline programs. The SAB formation fulfills a prior PIPE financing commi…
Broadcom Inc. announced a comprehensive suite of broadband Edge AI products, including a 50G PON gateway SoC, Wi-Fi 8 product family, and a joint 5G/Wi-Fi 8 fixed wireless access platform. These innovations are designed to support next-generation AI-driven applications by delivering ultra-low latency, enhanced security, and intelligent localized pr…
Merlin, Inc., an aerospace and defense technology company focused on autonomous flight systems, has announced its management will take part in multiple investor conferences throughout June 2026. The events include the Jefferies Defense Tech Summit, ROTH Capital Partners Annual London Conference, and the Maxim Group Defense Tech Conference. The comp…
Dave & Buster's Entertainment, Inc. will report its financial results for the first quarter ending May 5, 2026, on June 15, 2026 after market close. Management will host a conference call to discuss the results, providing insights into the company's ongoing operations and performance of its entertainment and dining venues.
Resmed has completed its acquisition of Noctrix Health, integrating the latter's FDA-approved, non-pharmacologic wearable therapy for Restless Legs Syndrome (RLS). This move broadens Resmed's product offerings in clinical sleep health and aims to enhance patient access and outcomes through connected health technologies.
Epsilon Energy Ltd. announced a quarterly dividend of $0.0625 per share payable June 30, 2026, and a borrowing base redetermination increasing the credit facility commitments to $90 million, with $40.5 million currently outstanding. The company operates across multiple North American natural gas and oil basins.
Pulmonx Corporation announced equity awards in the form of restricted stock units to 17 new employees as inducements to join the company in early 2026, following their 2025 Inducement Plan in compliance with Nasdaq Listing Rule 5635(c)(4). The awards include 84,300 RSUs with scheduled vesting over four years. Pulmonx is a market leader in minimally…
Fulcrum Therapeutics announced discontinuation of its pociredir program for sickle cell disease after receiving FDA feedback that raised concerns about the risk of secondary malignancies linked to the drug's target, influenced by a related drug's market withdrawal. Despite positive clinical signals, the FDA sees no viable regulatory path forward. F…
Heidmar Maritime Holdings Corp. disclosed the departure of CFO Niki Fotiou effective May 31, 2026, and initiated a search for her successor. CEO Pankaj Khanna will manage the finance function during the transition to ensure business continuity and no disruption is expected in financial reporting or operations.
Abivax reported positive Phase 3 ABTECT maintenance trial results for obefazimod, an oral miR-124 enhancer, showing significant clinical remission rates at week 44 in patients with moderately to severely active ulcerative colitis. Both 25 mg and 50 mg doses met primary and all key secondary endpoints with a favorable safety profile. The company pla…
Sonoco Products Company released its 2025 Corporate Sustainability Report showcasing significant advancements in renewable energy projects and sustainable packaging franchises. The company has reduced emissions substantially through various energy efficiency initiatives and earned several environmental awards, reflecting its commitment to sustainab…
Cardiff Oncology, a clinical-stage biotech company focused on developing cancer treatments through PLK1 inhibition, announced management's upcoming presentation and investor meetings at the Jefferies Global Healthcare Conference. The company’s lead drug, onvansertib, is being evaluated in Phase 2 trials for RAS-mutated metastatic colorectal cancer …
New Era Energy & Digital, Nasdaq-listed developer of next-generation digital infrastructure and power assets, announced key executive appointments to enhance its leadership team. Evan Pierce joins as Chief Development Officer, bringing over 20 years of experience in hyperscale data center and energy infrastructure development, while Michael Johnson…
Keros Therapeutics announced that its President and CEO Jasbir S. Seehra, Ph.D., will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026. The live webcast and replay will be available to investors. Keros is a clinical-stage biopharmaceutical company developing novel therapeutics targeting th…
Exicure, Inc. disclosed receipt of a Nasdaq notice due to delayed filing of its Q1 2026 Form 10-Q, which was subsequently filed, restoring compliance. The company is in a transition phase following restructuring, suspension of clinical activities, and is currently exploring strategic alternatives to maximize shareholder value while advancing a clin…
